Skip to content

Source filing unavailable

Q2 2025 · —
Revenue—
Net Income-$38.07Kno prior Q2 2024 on fileN/M vs Q1 2025
EPS, diluted—
Operating Income-$38,073—
Operating Cash Flowderived-$2,597—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q2 2024 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Drugs Made In America Acquisition II Corp. · CIK 2040475 · Engraved from SEC EDGAR